Addenda Capital Inc. Bellus Health Inc. Transaction History

Addenda Capital Inc.

  • $2.04 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 11, 2023
BUY
$7.14 - $8.53 $18,756 - $22,408
2,627 Added 4.64%
59,244 $426,000
Q4 2022

Jan 12, 2023
BUY
$8.22 - $10.76 $465,391 - $609,198
56,617 New
56,617 $0

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Addenda Capital Inc. Portfolio

Follow Addenda Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addenda Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Addenda Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email